SuperworthCardinal Health EPS CAH
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- $7.24
- Latest quarter, Q4 FY26
- $1.70
- +70% on a year earlier
- Fiscal year 2026
- $7.24
- +12% on the year before
Cardinal Health's earnings per share was $7.24 over the twelve months to Jun 30, 2026, up 12% on a year earlier.
In its latest quarter, Q4 FY26, it was $1.70, up 70% on the same quarter a year before.
Over the five fiscal years to FY2026 it grew 29% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | $7.24 | +12% |
| FY2025 | $6.45 | +86% |
| FY2024 | $3.47 | +251% |
| FY2023 | $0.99 | n/a |
| FY2022 | −$3.43 | −267% |
| FY2021 | $2.06 | n/a |
| FY2020 | −$12.47 | −376% |
| FY2019 | $4.51 | +509% |
| FY2018 | $0.74 | −82% |
| FY2017 | $4.04 | −6% |
| FY2016 | $4.32 | +19% |
| FY2015 | $3.62 | +7% |
| FY2014 | $3.38 | +256% |
| FY2013 | $0.95 | −69% |
| FY2012 | $3.06 | +12% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY26 | $1.70 | +70% | $7.24 | |
| Q3 FY26 | $1.69 | −20% | $6.54 | |
| Q2 FY26 | $1.97 | +19% | $6.95 | |
| Q1 FY26 | $1.88 | +11% | $6.63 | |
| Q4 FY25 | $1.00 | +5% | $6.45 | |
| Q3 FY25 | $2.10 | +96% | $6.40 | |
| Q2 FY25 | $1.65 | +10% | $5.37 | |
| Q1 FY25 | $1.70 | n/a | $5.22 | |
| Q4 FY24 | $0.95 | n/a | $3.47 | |
| Q3 FY24 | $1.07 | −20% | $2.27 | |
| Q2 FY24 | $1.50 | n/a | $2.54 | |
| Q1 FY24 | −$0.05 | −113% | $0.54 |
Against its peers
Companies in Medical - Distribution nearest Cardinal Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CAHCardinal Health | $7.24 | +12% a year |
| CORCencora | $13.46 | +38% a year |
| MCKMcKesson | $37.35 | +49% a year |
| HSICHenry Schein | $3.43 | +10% a year |
| Peer median | $13.46 |
Where Cardinal Health ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Cardinal Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.